PARP inhibitors in cancer: moving beyond BRCA.
| Autor: | Telli ML; Department of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, CA 94305, USA. mtelli@stanford.edu |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | The Lancet. Oncology [Lancet Oncol] 2011 Sep; Vol. 12 (9), pp. 827-8. Date of Electronic Publication: 2011 Aug 19. |
| DOI: | 10.1016/S1470-2045(11)70236-4 |
| Databáze: | MEDLINE |
| Externí odkaz: |
|